이 기사의 번역을 준비하고 있습니다. 그동안 영어 원문을 임시로 표시합니다.
비즈니스 · 1996. 4. 24.1 분 읽기
Personal Blood Storage of Memphis, Inc.; Opportunity for Hearing on a Proposal to Revoke U.S. License No. 1131
로컬 자동 번역 · 원본 출처 언어
요약
The Food and Drug Administration (FDA) is announcing an opportunity for a hearing on a proposal to revoke the establishment license (U.S. License No. 1131) and the product licenses issued to Personal Blood Storage of Memphis, Inc., for the manufacture of Whole Blood, Red Blood Cells, Plasma, and Platelets. The proposed revocation is based on the establishment's discontinuing of manufacturing of products to the extent that a meaningful inspection or evaluation cannot be made.
원본 출처 언어: Federal Register — Food and Drug Administration원문 발표 열기 →